Your browser doesn't support javascript.
loading
Newly proposed survival staging system for poorly differentiated thyroid cancer: a SEER-based study.
Sun, W; Wang, Z; Xiang, J; Qin, Y; Zhang, F; Zhang, H.
Afiliación
  • Sun W; Department of Thyroid Surgery, The First Hospital of China Medical University, No.155, Nanjing Bei Street, Heping District, Shenyang, 110001, Liaoning Province, China.
  • Wang Z; Department of Thyroid Surgery, The First Hospital of China Medical University, No.155, Nanjing Bei Street, Heping District, Shenyang, 110001, Liaoning Province, China.
  • Xiang J; Department of Thyroid Surgery, The First Hospital of China Medical University, No.155, Nanjing Bei Street, Heping District, Shenyang, 110001, Liaoning Province, China.
  • Qin Y; Department of Thyroid Surgery, The First Hospital of China Medical University, No.155, Nanjing Bei Street, Heping District, Shenyang, 110001, Liaoning Province, China.
  • Zhang F; Department of Hematology, Shengjing Hospital of China Medical University, No.39, Huaxiang Street, Tiexi District, Shenyang, China.
  • Zhang H; Department of Thyroid Surgery, The First Hospital of China Medical University, No.155, Nanjing Bei Street, Heping District, Shenyang, 110001, Liaoning Province, China. haozhang@cmu.edu.cn.
J Endocrinol Invest ; 46(5): 947-955, 2023 May.
Article en En | MEDLINE | ID: mdl-36484934
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Endocrinol Invest Año: 2023 Tipo del documento: Article País de afiliación: China